---
title: Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and
  Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell
  Carcinoma and Metastases
date: '2024-02-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38323498/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240207170748&v=2.18.0
source: heidelberg[Affiliation]
description: Beyond established anti-programmed cell death protein 1/programmed cell
  death ligand 1 immunotherapy, T-cell immunoreceptor with immunoglobulin and immunoreceptor
  tyrosine-based inhibition motif domain (TIGIT) and its ligand CD155 are promising
  novel inhibitory immune checkpoint targets in human malignancies. Yet, in cutaneous
  squamous cell carcinoma, evidence on the collective expression patterns of these
  inhibitory immune checkpoints is scarce. Complete tumour sections of 36 cutaneous
  ...
disable_comments: true
---
Beyond established anti-programmed cell death protein 1/programmed cell death ligand 1 immunotherapy, T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain (TIGIT) and its ligand CD155 are promising novel inhibitory immune checkpoint targets in human malignancies. Yet, in cutaneous squamous cell carcinoma, evidence on the collective expression patterns of these inhibitory immune checkpoints is scarce. Complete tumour sections of 36 cutaneous ...